These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1526415)

  • 1. [Demonstration of clonal heterogeneity in adenocarcinomas on Barrett's esophagus by flow cytometric study of cellular DNA content].
    Robaszkiewicz M; Volant A; Hardy E; Nousbaum JB; Calament G; Cauvin JM; Bail JP; Lozach P; Gouerou H
    Gastroenterol Clin Biol; 1992; 16(6-7):540-6. PubMed ID: 1526415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression to cancer in Barrett's esophagus is associated with genomic instability.
    Rabinovitch PS; Reid BJ; Haggitt RC; Norwood TH; Rubin CE
    Lab Invest; 1989 Jan; 60(1):65-71. PubMed ID: 2911184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Flow cytometric analysis of cellular DNA content in Barret's esophagus. A study of 66 cases].
    Robaszkiewicz M; Hardy E; Volant A; Nousbaum JB; Cauvin JM; Calament G; Robert FX; Saleun JP; Gouerou H
    Gastroenterol Clin Biol; 1991; 15(10):703-10. PubMed ID: 1816011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barrett's esophagus and esophageal adenocarcinoma.
    Reid BJ
    Gastroenterol Clin North Am; 1991 Dec; 20(4):817-34. PubMed ID: 1787015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistry.
    Krishnadath KK; Tilanus HW; Alers JC; Mulder AH; van Dekken H
    Cytometry; 1994 Feb; 15(2):176-84. PubMed ID: 8168405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas.
    Meltzer SJ; Yin J; Manin B; Rhyu MG; Cottrell J; Hudson E; Redd JL; Krasna MJ; Abraham JM; Reid BJ
    Cancer Res; 1994 Jul; 54(13):3379-82. PubMed ID: 8012954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent clonal areas and clonal expansion in Barrett's esophagus.
    Raskind WH; Norwood T; Levine DS; Haggitt RC; Rabinovitch PS; Reid BJ
    Cancer Res; 1992 May; 52(10):2946-50. PubMed ID: 1581911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA abnormalities as marker of risk for progression of Barrett's esophagus to adenocarcinoma: image cytometric DNA analysis in formalin-fixed tissues.
    Fang M; Lew E; Klein M; Sebo T; Su Y; Goyal R
    Am J Gastroenterol; 2004 Oct; 99(10):1887-94. PubMed ID: 15447746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of DNA content determination by image analysis in confirmation of dysplasia in Barrett's esophagus.
    Khan M; Bui HX; del Rosario A; Abdulla M; Ballouk F; Sim YJ; Ross JS
    Mod Pathol; 1994 Feb; 7(2):169-74. PubMed ID: 8008738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma.
    Blount PL; Ramel S; Raskind WH; Haggitt RC; Sanchez CA; Dean PJ; Rabinovitch PS; Reid BJ
    Cancer Res; 1991 Oct; 51(20):5482-6. PubMed ID: 1680552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53-mutant clones and field effects in Barrett's esophagus.
    Prevo LJ; Sanchez CA; Galipeau PC; Reid BJ
    Cancer Res; 1999 Oct; 59(19):4784-7. PubMed ID: 10519384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.
    Chatelain D; Fléjou JF
    Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barrett's esophagus: the biology of neoplastic progression.
    Neshat K; Sanchez CA; Galipeau PC; Levine DS; Reid BJ
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D71-6. PubMed ID: 8013790
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dna ploidy in adenocarcinoma of Barrett's esophagus].
    Flejou JF; Doublet B; Potet F; Metayer J; Hemet J
    Ann Pathol; 1990; 10(3):161-5. PubMed ID: 2386598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular biology of esophageal adenocarcinoma.
    Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
    J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma.
    Zhuang Z; Vortmeyer AO; Mark EJ; Odze R; Emmert-Buck MR; Merino MJ; Moon H; Liotta LA; Duray PH
    Cancer Res; 1996 May; 56(9):1961-4. PubMed ID: 8616831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of genetic abnormalities during neoplastic progression in Barrett's esophagus.
    Krishnadath KK; Tilanus HW; van Blankenstein M; Hop WC; Teijgeman R; Mulder AH; Bosman FT; van Dekken H
    Cancer Res; 1995 May; 55(9):1971-6. PubMed ID: 7728767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.